MK-4 may alleviate by protecting and promoting bone formation.
MK-4 improved type H vessel health and supported bone mass maintenance in a mouse model of diabetic osteoporosis.
In vitro experiments indicated that MK-4 could reverse endothelial cell dysfunction caused by high glucose conditions.
MK-4 enhanced the ability of osteoblasts to differentiate into bone-forming cells.
The beneficial effects of MK-4 on endothelial cells appear to involve PINK1/Parkin-mediated .
The ERK signaling pathway is suggested to play a critical role in MK-4's effects on mitophagy.
Simplified
PURPOSE: (DOP), one of the usual complications in diabetic patients, poses a significant threat to bone health. Type H vessels in metaphysis and medial cortical bone are associated with osteogenesis. As a form of Vitamin Kmenaquinone-4 (MK-4) is a potential treatment for osteoporosis. We aimed to investigate whether MK-4 ameliorates DOP by promoting bone formation through protecting type H vessels and its associated mechanisms. 2,
METHODS: High fat diet (HDF) feeding and streptozotocin (STZ) injection were applied to establish a mouse model of type 2 diabetic osteoporosis (T2DOP). Micro-CT, Masson staining, HE staining and IHC staining were applied to observe bone mass and the osteoblastic ability of osteoblasts. Tissue immunofluorescence (IF) staining and flow cytometry were employed to assess alteration of . In vitro, to evaluate the functional level and of ECs under high glucose conditions, wound healing assay, tube formation assay, EdU assay and IF were employed. Osteogenic differentiation ability in vitro was evaluated by ALP staining, AR staining, Western blot and RT-qPCR.
RESULTS: MK-4 alleviated type H vessel injury and angiogenesis-dependent osteogenesis in DOP mice, thereby maintaining the bone mass. The vitro results showed that MK-4 could mitigate the dysfunction of ECs subjected to HG treatment, and further facilitate the osteogenic differentiation of MC3T3-E1 cells. Moreover, mechanism exploration found that PINK1/Parkin-mediated mitophagy was required for the impact of MK-4 on ECs. Meanwhile, ERK signal pathway is necessary for the improvement of MK-4 in PINK1/Parkin-mediated mitophagy.
CONCLUSION: MK-4 is capable of alleviating the PINK1/Parkin-mediated mitophagy of ECs via the ERK pathway, thereby facilitating angiogenesis-dependent bone formation and further ameliorating DOP.
Key numbers
20
Mouse Cohort Size
Total number of male C57 BL/6 mice used in the study
30 mg/kg
MK-4 Dosage
Dosage of MK-4 administered to the + MK-4 group
15 mg/kg
3-MA Dosage
Dosage of 3-Methyladenine given to block MK-4's autophagy-promoting effects
Full Text
We can’t show the full text here under this license.